Medicinal Oxygen Air Liquide Sante

Country: European Union

Language: Danish

Source: EMA (European Medicines Agency)

Buy It Now

Patient Information leaflet Patient Information leaflet (PIL)
12-01-2007
Summary of Product characteristics Summary of Product characteristics (SPC)
12-01-2007
Public Assessment Report Public Assessment Report (PAR)
12-01-2007

Active ingredient:

ilt

Available from:

Air Liquide Santé International

ATC code:

QV03AN01

INN (International Name):

oxygen

Therapeutic group:

Horses; Dogs; Cats

Therapeutic area:

Alle andre terapeutiske produkter

Therapeutic indications:

Til ilttilskud og som bæregas under indåndingsbedøvelse. Til ilttilskud under genopretning.

Authorization status:

Trukket tilbage

Authorization date:

2006-12-20

Patient Information leaflet

                                Lægemidlet er ikke længere autoriseret til salg
B. INDLÆGSSEDDEL
12
Lægemidlet er ikke længere autoriseret til salg
INDLÆGSSEDDEL
MEDICINAL OXYGEN AIR LIQUIDE SANTÉ 100 % INHALATIONSGAS FOR HUNDE,
KATTE OG HESTE.
1.
NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN
SAMT PÅ DEN INDEHAVER AF VIRKSOMHEDSGODKENDELSE, SOM ER
ANSVARLIG FOR BATCHFRIGIVELSE, HVIS FORSKELLIG HERFRA
Indehaver af markedsføringstilladelsen 
                                
                                Read the complete document

Summary of Product characteristics

                                Lægemidlet er ikke længere autoriseret til salg
BILAG I
PRODUKTRESUME
1
Lægemidlet er ikke længere autoriseret til salg
1.
VETERINÆRLÆGEMIDLETS NAVN
Medicinal Oxygen Air Liquide Santé 100% inhalationsgas til hunde,
katte og heste.
2.
KVALITATIV OG KVANTITATIV SAMMENSÆTNING
AKTIVT STOF:
100 % oxygen.
3.
LÆGEMIDDELFORM.
Inhalationsgas.
4.
KLINISKE OPLYSNINGER.
4.1
DYREARTER, SOM LÆGEMIDLET ER BEREGNET TIL
Hunde, katte og heste.
4.2
TERAPEUTISKE INDIKATIONER MED ANGIVELSE AF DYREARTER, SOM LÆGEMIDLET
ER BEREGNET TIL
Som oxygensupplement og som bæregas under inhalations-anæstesi
Som oxygensupplement under rekonvalescens.
4.3
KONTRAINDIKATIONER
Ingen
4.4
SÆRLIGE ADVARSLER 
Ingen.
4.5
SÆRLIGE FORSIGTIGHEDSREGLER VEDRØRENDE BRUGEN
SÆRLIGE FORSIGTIGHEDSREGLER VEDRØRENDE BRUG TIL DYR
Oxygen i koncentration på op til 100 % (FiO
2
1.0) bør ikke overskride 12 timer. Oxygen i
koncentration på over 80 % (FiO
2
0.8) bør ikke overskride 18 timer.
Dyr, der allerede har eksisterende lungeskader forårsaget af
oxygen-radikaler, kan muligvis få denne
skade forværret ved oxygenterapi f.eks. ved behandling af
paraquatforgiftning.
SÆRLIGE FORSIGTIGHEDSREGLER FOR PERSONER, SOM INDGIVER LÆGEMIDLET
TIL DYR
Dette veterinærlægemiddel bør kun benyttes af personer, som er
blevet udførligt oplært til at benytte
trykregulatorer og andet tilsvarende udstyr.
2
Lægemidlet er ikke længere autoriseret til salg
Mens oxygen er ikke-brandbart, understøtter det forbrænding stærkt
og åben ild bør ikke være tilladt
tæt på beholderen. Da selv den mindste gnist kan forårsage kraftig
antændelse, bør elektrisk udstyr, der
er i stand til at slå gnister, ikke benyttes i nærheden af
patienter, der modtager oxygen.
Ventiler på cylindere, gasflasker og lignende udstyr må ikke være
smurte og skal holdes fuldstændig
fri for carbonbaseret olier og smørelse, da der ellers er risiko for
spontan forbrænding og der kan opstå
en kraftig eksplosion.
Hvis du har ar
                                
                                Read the complete document

Similar products

Active ingredient ilt

ilt

ATC code QV03AN01

QV03AN01

Marketed by Air Liquide Santé International

Air Liquide Santé International

INN (International Name) oxygen

oxygen

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Bulgarian 12-01-2007
Public Assessment Report Public Assessment Report Bulgarian 12-01-2007
Patient Information leaflet Patient Information leaflet Spanish 12-01-2007
Summary of Product characteristics Summary of Product characteristics Spanish 12-01-2007
Public Assessment Report Public Assessment Report Spanish 12-01-2007
Patient Information leaflet Patient Information leaflet Czech 12-01-2007
Summary of Product characteristics Summary of Product characteristics Czech 12-01-2007
Public Assessment Report Public Assessment Report Czech 12-01-2007
Patient Information leaflet Patient Information leaflet German 12-01-2007
Summary of Product characteristics Summary of Product characteristics German 12-01-2007
Public Assessment Report Public Assessment Report German 12-01-2007
Patient Information leaflet Patient Information leaflet Estonian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Estonian 12-01-2007
Public Assessment Report Public Assessment Report Estonian 12-01-2007
Patient Information leaflet Patient Information leaflet Greek 12-01-2007
Summary of Product characteristics Summary of Product characteristics Greek 12-01-2007
Public Assessment Report Public Assessment Report Greek 12-01-2007
Patient Information leaflet Patient Information leaflet English 12-01-2007
Summary of Product characteristics Summary of Product characteristics English 12-01-2007
Public Assessment Report Public Assessment Report English 12-01-2007
Patient Information leaflet Patient Information leaflet French 12-01-2007
Summary of Product characteristics Summary of Product characteristics French 12-01-2007
Public Assessment Report Public Assessment Report French 12-01-2007
Patient Information leaflet Patient Information leaflet Italian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Italian 12-01-2007
Public Assessment Report Public Assessment Report Italian 12-01-2007
Patient Information leaflet Patient Information leaflet Latvian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Latvian 12-01-2007
Public Assessment Report Public Assessment Report Latvian 12-01-2007
Patient Information leaflet Patient Information leaflet Lithuanian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Lithuanian 12-01-2007
Public Assessment Report Public Assessment Report Lithuanian 12-01-2007
Patient Information leaflet Patient Information leaflet Hungarian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Hungarian 12-01-2007
Public Assessment Report Public Assessment Report Hungarian 12-01-2007
Patient Information leaflet Patient Information leaflet Maltese 12-01-2007
Summary of Product characteristics Summary of Product characteristics Maltese 12-01-2007
Patient Information leaflet Patient Information leaflet Dutch 12-01-2007
Summary of Product characteristics Summary of Product characteristics Dutch 12-01-2007
Public Assessment Report Public Assessment Report Dutch 12-01-2007
Patient Information leaflet Patient Information leaflet Polish 12-01-2007
Summary of Product characteristics Summary of Product characteristics Polish 12-01-2007
Public Assessment Report Public Assessment Report Polish 12-01-2007
Patient Information leaflet Patient Information leaflet Portuguese 12-01-2007
Summary of Product characteristics Summary of Product characteristics Portuguese 12-01-2007
Public Assessment Report Public Assessment Report Portuguese 12-01-2007
Patient Information leaflet Patient Information leaflet Romanian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Romanian 12-01-2007
Public Assessment Report Public Assessment Report Romanian 12-01-2007
Patient Information leaflet Patient Information leaflet Slovak 12-01-2007
Summary of Product characteristics Summary of Product characteristics Slovak 12-01-2007
Public Assessment Report Public Assessment Report Slovak 12-01-2007
Patient Information leaflet Patient Information leaflet Slovenian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Slovenian 12-01-2007
Public Assessment Report Public Assessment Report Slovenian 12-01-2007
Patient Information leaflet Patient Information leaflet Finnish 12-01-2007
Summary of Product characteristics Summary of Product characteristics Finnish 12-01-2007
Public Assessment Report Public Assessment Report Finnish 12-01-2007
Patient Information leaflet Patient Information leaflet Swedish 12-01-2007
Summary of Product characteristics Summary of Product characteristics Swedish 12-01-2007
Public Assessment Report Public Assessment Report Swedish 12-01-2007

Search alerts related to this product

Alerts Medicinal Oxygen Air Liquide ilt

Medicinal Oxygen Air Liquide ilt

View documents history

Documents history Documents history

Medicinal Oxygen Air Liquide Sante